论文部分内容阅读
目的观察疏血通注射液联合低分子肝素钙治疗脑梗死急性期的临床效果。方法将116例急性脑梗死患者随机分为两组,治疗组58例用疏血通注射液联合低分子肝素钙治疗,对照组58例单纯用低分子肝素钙治疗。治疗前后分别测定血液流变学参数,并进行神经功能缺损程度评分和疗效比较。结果治疗组总有效率明显高于对照组(P<0.05),神经功能缺损评分减少程度明显优于对照组(P<0.05),且无不良反应。结论疏血通对治疗急性脑梗死有较好的疗效。
Objective To observe the clinical effect of Shuxuetong injection combined with low molecular weight heparin in the treatment of acute cerebral infarction. Methods A total of 116 patients with acute cerebral infarction were randomly divided into two groups. 58 patients in the treatment group were treated with Shuxuetong injection combined with low molecular weight heparin calcium, and 58 in the control group were treated with low molecular weight heparin calcium alone. Blood rheology parameters were measured before and after treatment, and the degree of neurological deficit score and efficacy comparison. Results The total effective rate in the treatment group was significantly higher than that in the control group (P <0.05). The degree of neurological deficit reduction was significantly better than that in the control group (P <0.05), and no adverse reactions were found. Conclusion Shuxuetong in the treatment of acute cerebral infarction have a good effect.